| MiR-19b non-canonical binding is directed by HuR and confers chemosensitivity through regulation of P-glycoprotein in breast cancer JL Thorne, S Battaglia, DE Baxter, JL Hayes, SA Hutchinson, S Jana, ... Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1861 (11 …, 2018 | 32 | 2018 |
| MiR-195 and its target SEMA6D regulate chemoresponse in breast cancer DE Baxter, LM Allinson, WS Al Amri, JA Poulter, A Pramanik, JL Thorne, ... Cancers 13 (23), 5979, 2021 | 23 | 2021 |
| Genomic and expression analyses define MUC17 and PCNX1 as predictors of chemotherapy response in breast cancer WS Al Amri, LM Allinson, DE Baxter, SM Bell, AM Hanby, SJ Jones, ... Molecular cancer therapeutics 19 (3), 945-955, 2020 | 16 | 2020 |
| Neoadjuvant endocrine therapy in breast cancer upregulates the cytotoxic drug pump ABCG2/BCRP, and may lead to resistance to subsequent chemotherapy DE Baxter, B Kim, AM Hanby, ET Verghese, AH Sims, TA Hughes Clinical breast cancer 18 (6), 481-488, 2018 | 15 | 2018 |
| Identification of candidate mediators of chemoresponse in breast cancer through therapy-driven selection of somatic variants WS Al Amri, DE Baxter, AM Hanby, LF Stead, ET Verghese, JL Thorne, ... Breast cancer research and treatment 183, 607-616, 2020 | 14 | 2020 |
| Molecular Mechanisms of Chemotherapy Resistance in Oestrogen Receptor Positive Breast Cancer DE Baxter University of Leeds, 2019 | | 2019 |
| 31. Neoadjuvant Endocrine Therapy in Breast Cancer Up-Regulates the Cytotoxic Drug Pump ABCG2/BCRP, and May Lead to Resistance to Subsequent Chemotherapy B Kim, D Baxter, A Hanby, E Verghese, A Sims, T Hughes European Journal of Surgical Oncology 44 (11), 1840, 2018 | | 2018 |
| Regulation of Ciz1 by Cyclin A-Cyclin Dependent Kinase 2 (CDK2) Mediated Phosphorylation D Baxter PQDT-Global, 2016 | | 2016 |
